NIH's limited competition supports clinical and translational research workforce and infrastructure development in states that have historically received low levels of NIH funding.
Funder: National Institutes of Health
Due Dates: January 28, 2027 (Application) | May 28, 2027 (Application) | September 28, 2027 (Application) | January 28, 2028 (Application) | May 30, 2028 (Application) | September 28, 2028 (Application) | January 29, 2029 (Application) | May 30, 2029 (Final application)
Funding Amounts: CTR-D: up to $1 million in year 1 and $1.75 million annually in years 2–5; CTR-N: up to $3 million in year 1 and $3.5 million annually in years 2–5 (direct costs; maximum 5 years)
Summary: Builds clinical and translational research infrastructure, workforce, and networks addressing health challenges prevalent in IDeA-eligible states.
Key Information: Limited competition: all lead and partner organizations must be in IDeA-eligible states and cannot participate in an active CTSA.
The National Institute of General Medical Sciences (NIGMS), part of NIH, administers this limited-competition P30 Center Core Grant opportunity to build clinical and translational (C&T) research capacity in states that historically received low levels of NIH funding. It supports infrastructure, workforce development, and coordinated research addressing diseases and health challenges prevalent in those states. Clinical trials are optional.
The program offers a Development track (CTR-D) for health research organizations with limited clinical research capacity and a Network track (CTR-N) for statewide or multi-state networks expanding existing capacity. Networks may include health research organizations, community clinics, and Practice-Based Research Networks (PBRNs). Applicants must justify their track choice and propose broad capacity-building programs rather than narrowly disease- or population-focused applications.